Claims
- 1. An isolated nucleic acid molecule comprising SEQ ID NO:1, wherein position 89837 of SEQ ID NO:1 is ‘T’ instead of ‘C’.
- 2. A nucleic acid probe that is complementary over the entire length of said probe to a segment of SEQ ID NO:1 that includes position 89837 of SEQ ID NO: 1, wherein position 89837 of SEQ ID NO: 1 is ‘T’ instead of ‘C’, such that the probe hybridizes under high stringency conditions to a nucleic acid molecule comprising said segment of SEQ ID NO: 1 but does not hybridize to a nucleic acid molecule comprising said segment of SEQ ID NO: 1 having a ‘C’ at position 89837, wherein said high stringency conditions are hybridization in 6× sodium chloride/sodium citrate (SSC) at about 45° C., followed by one or more washes in 0.2×SSC, 0.1% SDS at 50-65° C.
- 3. The probe of claim 2, wherein the probe is detectably labeled.
- 4. An isolated nucleic acid molecule that is entirely complementary to the nucleic acid molecule of claim 1.
RELATED APPLICATIONS
The present application claims priority to provisional application U.S. Ser. No. 60/183,755, filed Feb. 22, 2000.
Non-Patent Literature Citations (5)
Entry |
Stratagene Catalog 1991, p. 66.* |
Rosenkranz et al; “Systematic Mutation Screening . . . ”; Jnl of Clncl Endocrinology and Metabolism; 1998; vol. 88 No. 12; pp. 4524, 4526. |
Albagha O et al.; “Estrogen Receptor -alpha and -beta . . . ”; Calcified Thissue International; vol. 64 No. Suppl; 1999, p. S86. |
Kazuhiro Tsukamoto et al.; “Isolation and radiation hybrid mapping . . .”; J Hum Genet (1998) 43:73-74. |
Mosselman et al.; “Erβ: identification and characterization of . . . ”; FEBS Letters (1996) 49-53. |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/183755 |
Feb 2000 |
US |